Humana Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Humana's earnings have been declining at an average annual rate of -8%, while the Healthcare industry saw earnings growing at 20% annually. Revenues have been growing at an average rate of 6.7% per year. Humana's return on equity is 3.8%, and it has net margins of 1.2%.
Belangrijke informatie
-8.0%
Groei van de winst
-5.6%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.1% |
| Inkomstengroei | 6.7% |
| Rendement op eigen vermogen | 3.8% |
| Nettomarge | 1.2% |
| Volgende winstupdate | 06 Feb 2025 |
Recente prestatie-updates uit het verleden
Recent updates
Why Humana's (STO:HUM) Shaky Earnings Are Just The Beginning Of Its Problems
Oct 31
kr49.00 - That's What Analysts Think Humana AB (publ) (STO:HUM) Is Worth After These Results
Oct 27Humana AB (publ) (STO:HUM) Released Earnings Last Week And Analysts Lifted Their Price Target To kr39.50
Jul 22Humana AB (publ) (STO:HUM) Doing What It Can To Lift Shares
Apr 09Humana AB (publ) (STO:HUM) Just Released Its Full-Year Earnings: Here's What Analysts Think
Feb 12Does Humana (STO:HUM) Have A Healthy Balance Sheet?
Mar 18At kr20.50, Is It Time To Put Humana AB (publ) (STO:HUM) On Your Watch List?
Feb 01Is Humana (STO:HUM) Using Too Much Debt?
Oct 21Is It Too Late To Consider Buying Humana AB (publ) (STO:HUM)?
Mar 31Is Humana (STO:HUM) Using Too Much Debt?
Nov 22Shareholders Can Be Confident That Humana's (STO:HUM) Earnings Are High Quality
Aug 28Opbrengsten en kosten
Hoe Humana geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 10,014 | 124 | 1,176 | 0 |
| 30 Jun 24 | 9,746 | 110 | 1,167 | 0 |
| 31 Mar 24 | 9,621 | 146 | 1,177 | 0 |
| 31 Dec 23 | 9,649 | 176 | 1,200 | 0 |
| 30 Sep 23 | 9,685 | 228 | 1,211 | 0 |
| 30 Jun 23 | 9,660 | 250 | 1,176 | 0 |
| 31 Mar 23 | 9,491 | 232 | 1,122 | 0 |
| 31 Dec 22 | 9,203 | 210 | 1,082 | 0 |
| 30 Sep 22 | 8,869 | 183 | 1,037 | 0 |
| 30 Jun 22 | 8,530 | 203 | 988 | 0 |
| 31 Mar 22 | 8,347 | 242 | 963 | 0 |
| 31 Dec 21 | 8,186 | 276 | 926 | 0 |
| 30 Sep 21 | 8,000 | 293 | 891 | 0 |
| 30 Jun 21 | 7,896 | 279 | 896 | 0 |
| 31 Mar 21 | 7,825 | 272 | 902 | 0 |
| 31 Dec 20 | 7,771 | 262 | 913 | 0 |
| 30 Sep 20 | 7,750 | 230 | 86 | 0 |
| 30 Jun 20 | 7,739 | 249 | 104 | 0 |
| 31 Mar 20 | 7,670 | 197 | 113 | 0 |
| 31 Dec 19 | 7,446 | 188 | 89 | 0 |
| 30 Sep 19 | 7,247 | 222 | -57 | 0 |
| 30 Jun 19 | 7,005 | 196 | -34 | 0 |
| 31 Mar 19 | 6,774 | 245 | -21 | 0 |
| 31 Dec 18 | 6,714 | 246 | 25 | 0 |
| 30 Sep 18 | 6,600 | 228 | 239 | 0 |
| 30 Jun 18 | 6,550 | 197 | 226 | 0 |
| 31 Mar 18 | 6,541 | 199 | 218 | 0 |
| 31 Dec 17 | 6,542 | 194 | 212 | 0 |
| 30 Sep 17 | 6,635 | 195 | 279 | 0 |
| 30 Jun 17 | 6,684 | 241 | 287 | 0 |
| 31 Mar 17 | 6,540 | 226 | 263 | 0 |
| 31 Dec 16 | 6,362 | 148 | 218 | 0 |
| 30 Sep 16 | 6,140 | 139 | 288 | 0 |
| 30 Jun 16 | 5,868 | -11 | 230 | 0 |
| 31 Mar 16 | 5,713 | -53 | 185 | 0 |
| 31 Dec 15 | 5,593 | 28 | 157 | 0 |
| 31 Dec 14 | 5,065 | 38 | 129 | 0 |
| 31 Dec 13 | 3,489 | 111 | 58 | 0 |
Kwaliteitswinsten: HUM has a large one-off gain of SEK76.0M impacting its last 12 months of financial results to 30th September, 2024.
Groeiende winstmarge: HUM's current net profit margins (1.2%) are lower than last year (2.4%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: HUM's earnings have declined by 8% per year over the past 5 years.
Versnelling van de groei: HUM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: HUM had negative earnings growth (-45.6%) over the past year, making it difficult to compare to the Healthcare industry average (16.3%).
Rendement op eigen vermogen
Hoge ROE: HUM's Return on Equity (3.8%) is considered low.